Louis Coupal

2.6k total citations · 1 hit paper
61 papers, 1.8k citations indexed

About

Louis Coupal is a scholar working on Surgery, Economics and Econometrics and Rheumatology. According to data from OpenAlex, Louis Coupal has authored 61 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 19 papers in Economics and Econometrics and 18 papers in Rheumatology. Recurrent topics in Louis Coupal's work include Health Systems, Economic Evaluations, Quality of Life (19 papers), Lipoproteins and Cardiovascular Health (16 papers) and Rheumatoid Arthritis Research and Therapies (15 papers). Louis Coupal is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (19 papers), Lipoproteins and Cardiovascular Health (16 papers) and Rheumatoid Arthritis Research and Therapies (15 papers). Louis Coupal collaborates with scholars based in Canada, United States and United Kingdom. Louis Coupal's co-authors include Steven A. Grover, Lawrence Joseph, Theresa W. Gyorkos, Hanna Zowall, Ilka Lowensteyn, Mohammed Kaouache, Sylvie Marchand, Marc Dorais, Isabelle Defoy and Carey Levinton and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Diabetes Care.

In The Last Decade

Louis Coupal

57 papers receiving 1.7k citations

Hit Papers

Bayesian Estimation of Disease Prevalence and the Paramet... 1995 2026 2005 2015 1995 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louis Coupal Canada 20 383 379 350 242 211 61 1.8k
T. Craig Cheetham United States 37 581 1.5× 254 0.7× 264 0.8× 365 1.5× 356 1.7× 96 3.4k
Paul Arora Canada 24 418 1.1× 265 0.7× 194 0.6× 251 1.0× 45 0.2× 67 2.3k
Judith A. O’Brien Canada 22 175 0.5× 290 0.8× 394 1.1× 202 0.8× 93 0.4× 43 1.9k
Ross Harris United Kingdom 25 503 1.3× 178 0.5× 341 1.0× 175 0.7× 73 0.3× 68 3.9k
J Morris United Kingdom 22 542 1.4× 121 0.3× 314 0.9× 170 0.7× 55 0.3× 40 2.9k
G. David Williamson United States 12 358 0.9× 78 0.2× 334 1.0× 341 1.4× 33 0.2× 17 2.3k
Paul F. Griner United States 18 255 0.7× 237 0.6× 50 0.1× 194 0.8× 77 0.4× 47 2.3k
Mary Southworth United States 18 194 0.5× 273 0.7× 81 0.2× 1.3k 5.6× 32 0.2× 31 3.0k
Edith Lau Hong Kong 20 429 1.1× 217 0.6× 272 0.8× 76 0.3× 29 0.1× 25 4.0k
Patrick Taffé Switzerland 32 468 1.2× 128 0.3× 80 0.2× 394 1.6× 49 0.2× 105 3.0k

Countries citing papers authored by Louis Coupal

Since Specialization
Citations

This map shows the geographic impact of Louis Coupal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Coupal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Coupal more than expected).

Fields of papers citing papers by Louis Coupal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Coupal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Coupal. The network helps show where Louis Coupal may publish in the future.

Co-authorship network of co-authors of Louis Coupal

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Coupal. A scholar is included among the top collaborators of Louis Coupal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Coupal. Louis Coupal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gladman, Dafna D., Vinod Chandran, Cheryl F. Rosen, et al.. (2024). Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA). The Journal of Rheumatology. 51(5). 479–487. 2 indexed citations
3.
Movahedi, Mohammad, D. Choquette, Louis Coupal, et al.. (2023). Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada. BMJ Open. 13(3). e063198–e063198. 4 indexed citations
4.
Lopatina, Elena, Deborah A. Marshall, Louis Coupal, Jacques Le Lorier, & D. Choquette. (2020). Cost–utility analysis of second-line therapy with rituximab compared to tumour necrosis factor inhibitors in rheumatoid arthritis. Current Medical Research and Opinion. 37(1). 157–166. 6 indexed citations
5.
Choquette, D., Louis Bessette, Frédéric Massicotte, et al.. (2019). AB0740 USE OF SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS. IMPACTS OF COMBINATION WITH METHOTREXATE. Annals of the Rheumatic Diseases. 78. 1835–1835. 3 indexed citations
6.
Choquette, D., Louis Bessette, Frédéric Massicotte, et al.. (2019). SAT0120 COMPARATIVE EFFECTIVENESS OF TOFACITINIB AND TNF INHIBITORS SINCE 2014. IMPACT OF COMBINATION WITH METHOTREXATE. Annals of the Rheumatic Diseases. 78. 1128–1128. 3 indexed citations
7.
Grover, Steven A., et al.. (2011). Estimating the Benefits of Patient and Physician Adherence to Cardiovascular Prevention Guidelines: The MyHealthCheckup Survey. Canadian Journal of Cardiology. 27(2). 159–166. 15 indexed citations
8.
Grover, Steven A., Louis Coupal, & Ilka Lowensteyn. (2007). Estimating the Cost Effectiveness of Ramipril used for Specific Clinical Indications. American Journal of Cardiovascular Drugs. 7(6). 441–448. 4 indexed citations
9.
Grover, Steven A., Ilka Lowensteyn, Mohammed Kaouache, et al.. (2006). The Prevalence of Erectile Dysfunction in the Primary Care Setting. Archives of Internal Medicine. 166(2). 213–213. 198 indexed citations
11.
Grover, Steven A., Marc Dorais, & Louis Coupal. (2003). . Epidemiology. 14(3). 315–320. 2 indexed citations
12.
Grover, Steven A., Marc Dorais, & Louis Coupal. (2003). Improving the Prediction of Cardiovascular Risk: Interaction Between LDL and HDL Cholesterol. Epidemiology. 14(3). 315–320. 21 indexed citations
13.
Grover, Steven A., Marc Dorais, Gilles Paradis, et al.. (2000). Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines.. PubMed. 163(10). 1263–9. 15 indexed citations
14.
Lowensteyn, Ilka, Louis Coupal, Hanna Zowall, & Steven A. Grover. (2000). The Cost-Effectiveness of Exercise Training for the Primary and Secondary Prevention of Cardiovascular Disease. Journal of Cardiopulmonary Rehabilitation. 20(3). 147–155. 60 indexed citations
15.
Grover, Steven A., Hanna Zowall, Louis Coupal, & Murray Krahn. (1999). Prostate cancer: 12. The economic burden.. PubMed. 160(5). 685–90. 19 indexed citations
16.
Grover, Steven A., et al.. (1998). Estimating the Benefits of Modifying Risk Factors of Cardiovascular Disease. Archives of Internal Medicine. 158(6). 655–655. 115 indexed citations
17.
Grover, Steven A., et al.. (1994). The Nursing Care Needs of Hospitalized AIDS Patients. Aids Patient Care. 8(2). 64–67. 1 indexed citations
18.
Zowall, Hanna, et al.. (1992). Economic impact of HIV infection and coronary heart disease in immigrants to Canada.. Europe PMC (PubMed Central). 147(8). 1163–72. 7 indexed citations
19.
Barkun, Alan, et al.. (1991). The bedside assessment of splenic enlargement. The American Journal of Medicine. 91(5). 512–518. 25 indexed citations
20.
Barkun, Alan, et al.. (1989). Splenic enlargement and traube's space: How useful is percussion?☆. The American Journal of Medicine. 87. 562–566. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026